Log In

Home
    - Create Journal
    - Update
    - Download

Scribbld
    - News
    - Paid Accounts
    - Invite
    - To-Do list
    - Contributors

Customize
    - Customize
    - Create Style
    - Edit Style

Find Users
    - Random!
    - By Region
    - By Interest
    - Search

Edit ...
    - User Info
    - Settings
    - Your Friends
    - Old Entries
    - Userpics
    - Password

Need Help?
    - Password?
    - FAQs
    - Support Area


Someone wrote in [info]kzehsutcyc,
MstOnNAxveTFfR
I'm in a band how to take prosolution McHutchison said data on another Gilead all-oral regimen - sofosbuvir combined with NS5A inhibitor ledipasvir - will be presented at a medical meeting next April. The company plans to file for FDA approval of that regimen, which includes genotype 1 patients, in the first half of next year.

(Read comments)

Post a comment in response:

From:
( )Anonymous- this user has disabled anonymous and non-friend posting. You may post here if kzehsutcyc lists you as a friend.
Identity URL: 
Username:
Password:
Don't have an account? Create one now.
Subject:
No HTML allowed in subject
  
Message:

Type the letters and numbers you see below, to prove that you're not a spam robot. If you can't read the text, type "AUDIO" and take a sound test instead.


Answer:

 



scribbld is part of the horse.13 network
Design by Jimmy B.
Logo created by hitsuzen.
Scribbld System Status